tiprankstipranks
TME Pharma N.V. (FR:ALTME)
:ALTME
France Market
Want to see FR:ALTME full AI Analyst Report?

TME Pharma N.V. (ALTME) Financial Statements

3 Followers

TME Pharma N.V. Financial Overview

TME Pharma N.V.'s market cap is currently €7.96M. The company's EPS TTM is €-0.0326; its P/E ratio is -1.87; TME Pharma N.V. is scheduled to report earnings on April 29, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue€ 0.00€ 19.00K€ 17.00K€ 0.00€ 33.00K
Gross Profit€ -8.00K€ -78.00K€ -127.00K€ -92.00K€ -65.97K
Operating Income€ -2.91M€ -5.28M€ -5.62M€ -12.03M€ -13.27M
EBITDA€ -2.90M€ -5.25M€ -5.07M€ -11.63M€ -12.88M
Net Income€ -3.29M€ -5.72M€ -6.74M€ -15.13M€ -14.45M
Balance Sheet
Cash & Short-Term Investments€ 2.02M€ 3.25M€ 2.25M€ 4.63M€ 9.48M
Total Assets€ 2.14M€ 3.41M€ 2.49M€ 5.24M€ 9.77M
Total Debt€ 2.66M€ 56.00K€ 1.17M€ 4.09M€ 2.44M
Net Debt€ 644.00K€ -3.24M€ -1.08M€ -548.00K€ -7.02M
Total Liabilities€ 3.72M€ 1.79M€ 2.79M€ 6.51M€ 5.27M
Stockholders' Equity€ -1.58M€ 1.61M€ -294.00K€ -1.27M€ 4.51M
Cash Flow
Free Cash Flow€ -3.42M€ -4.65M€ -5.65M€ -12.16M€ -12.39M
Operating Cash Flow€ -3.42M€ -4.63M€ -5.63M€ -12.14M€ -12.38M
Investing Cash Flow€ 8.00K€ -21.00K€ -19.00K€ -21.00K€ -14.00K
Financing Cash Flow€ 2.18M€ 5.66M€ 3.27M€ 7.29M€ 11.50M
Currency in EUR

TME Pharma N.V. Earnings and Revenue History

TME Pharma N.V. Debt to Assets

TME Pharma N.V. Cash Flow

TME Pharma N.V. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.